Building a Medical School
come true for downtown Phoenix; Building a new medical school
For six local doctors, the creation of what is now one of the newest medical colleges in the nation seemed a distant dream. These seasoned professionals have invested many years, personal and professional commitment, expertise and downright tenacity, to make this campus and this college a reality. All contributed from their respective fields and their respective hospitals. All were teachers and saw the need for the development of the University of Arizona College of Medicine - Phoenix. Read more at: http://phoenixmed.arizona.edu
From Bioscience to Biobusiness Success
Dr. Robert Bowser was recruited to the Barrow Neurological Institute and St. Joseph’s Hospital & Medical Center to direct an ALS research center using philanthropic support from Mr. Ira Fulton. He arrived to the Phoenix area in August of last year after 18 years on the faculty at the University of Pittsburgh School of Medicine. Dr. Bowser’s research focuses on biomarkers of neurologic disease and he will describe how success in his academic research has also led to success in the world of biotechnology.
Senestech: Humane Pest Control
Harry A. George, 2012 Bioscience Leader of the Year
For close to four decades, Harry George has been creating, capitalizing, and operating rapid-growth technology companies.
A quiet, action oriented leader. Harry has consistently driven Arizona’s bioscience and technology sectors forward by acting on his vision with commitment, dedication, and determination.
In recognition of his service and accomplishments, Harry A. George is the 2012 Jon W. McGarity Bioscience Leader of the Year
AHSC: Helping People Live Better Longer
Iron Horse Diagnostics - 2013 AZBio Fast Lane Honoree
Iron Horse Diagnostics was honored with the 2013 AZBio Fast Lane Award from the Arizona Bioindustry Association for Accelerating the Development of New ALS Diagnostic Tests.
Amyotrophic Lateral Sclerosis (also known as ALS or Lou Gehrig’s disease) is a devastating disease that is nearly always fatal within 5 years of onset. Due to similarities in their symptomatic progression is it difficult to differentiate ALS from several other disease mimics (motor neuropathy, progressive muscle atrophy, etc.) until it is too late for intervention to have any real effect. With an earlier diagnosis, and therefore earlier intervention, current clinical care may increase the lifespan of these patients and additional drug therapies that are likely to be introduced to the market could be more rapidly initiated. Not only might life expectancy increase, but patients would be given the chance for a higher quality of life for a longer duration due to more rapid inclusion of the patient into multi-disciplinary care treatment offered at specialized ALS clinics.
2012 Bioscience Company of the Year - Cord Blood Registry
The first cord blood sample ever saved by a family belonged to the son of CBR's Scientific Director.
Two decades later, CBR (Cord Blood Registry) is the largest, most experienced stem cell bank, entrusted by families worldwide.Thanks to expecting families like yours, more than 400,000 children have newborn stem cells saved with CBR. As you decide what's best for your family, it's important to understand the CBR difference in quality and experience. CBR has banked more stem cells than any other family bank and has the most experience helping families use their cord blood for medical treatments.
In October 2012, CBR was named the Arizona Bioscience Company of the Year.